000 | 01866 a2200529 4500 | ||
---|---|---|---|
005 | 20250517051107.0 | ||
264 | 0 | _c20160701 | |
008 | 201607s 0 0 eng d | ||
022 | _a1768-3114 | ||
024 | 7 |
_a10.1016/j.patbio.2015.06.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBeaumont-Epinette, M-P | |
245 | 0 | 0 |
_aHeavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients. _h[electronic resource] |
260 |
_bPathologie-biologie _cSep 2015 |
||
300 |
_a215-21 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBlood Protein Electrophoresis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoelectrophoresis |
650 | 0 | 4 |
_aImmunoglobulin A _xblood |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunoglobulin Heavy Chains _xblood |
650 | 0 | 4 |
_aImmunoglobulin Light Chains _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Myeloma _xblood |
650 | 0 | 4 |
_aMyeloma Proteins _xanalysis |
650 | 0 | 4 | _aNeoplasm, Residual |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMoreau, C | |
700 | 1 | _aBesnard, S | |
700 | 1 | _aLatute, F | |
700 | 1 | _aCollet, N | |
700 | 1 | _aSebillot, M | |
700 | 1 | _aGrosbois, B | |
700 | 1 | _aBendavid, C | |
700 | 1 | _aGuenet, L | |
700 | 1 | _aDecaux, O | |
773 | 0 |
_tPathologie-biologie _gvol. 63 _gno. 4-5 _gp. 215-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.patbio.2015.06.001 _zAvailable from publisher's website |
999 |
_c25214165 _d25214165 |